BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1849200)

  • 1. [Clinical significance and the problems of HCV antibody].
    Yano M
    Nihon Rinsho; 1991 Feb; 49(2):402-8. PubMed ID: 1849200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical features of anti-HCV antibody positive hepatocellular carcinoma].
    Hayashi S; Tanaka S; Wakashima M; Saeki S; Tanaka T; Shibayama T; Otake H; Hattori N
    Nihon Rinsho; 1991 Feb; 49(2):432-8. PubMed ID: 1849205
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
    Yu ZY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C virus and serologic tests for detection of viral hepatitis C].
    Bode JC; Alscher DM
    Med Klin (Munich); 1992 Oct; 87(10):527-31, 549. PubMed ID: 1334216
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
    Goeser T; Theilmann L
    Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia.
    Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R
    Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
    Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
    Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus].
    Garassini MA
    G E N; 1990; 44(1):67-70. PubMed ID: 1967084
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C virus antibodies in patients following blood transfusion and kidney transplantation].
    Baur P; Daniel V; Pomer S; Scheurlen H; Opelz G; Roelcke D
    Beitr Infusionsther; 1991; 28():27-8. PubMed ID: 1725637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C.
    Alter MJ
    Arch Pathol Lab Med; 1994 Apr; 118(4):342-5. PubMed ID: 7513149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
    Matsuoka S; Tatara K; Hayabuchi Y; Taguchi Y; Mori K; Honda H; Itou S; Yuasa Y; Kuroda Y
    Pediatrics; 1994 Dec; 94(6 Pt 1):919-22. PubMed ID: 7971011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C virus in chronic hepatitis and liver cirrhosis].
    Yamada G; Endo H; Takahashi M; Tsuji T
    Nihon Rinsho; 1991 Feb; 49(2):426-31. PubMed ID: 1849204
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mother-to-infant infection by hepatitis C virus].
    Shiraki K; Nagata I; Okada T; Tanimoto K
    Nihon Rinsho; 1991 Feb; 49(2):372-7. PubMed ID: 1849195
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characterization of hepatitis C related markers and control of hepatitis C infection].
    Yoshizawa H
    Nihon Koshu Eisei Zasshi; 1992 Aug; 39(8):441-4. PubMed ID: 1327295
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibodies against hepatitis C virus in patients with liver diseases and in risk subjects. Preliminary report].
    Garassini MA; Ortega F; Valdés A; Alvarado M; Cid A; Serrano L; Torres G; Hagen E; Dugarte I; Pérez N
    G E N; 1990; 44(4):343-8. PubMed ID: 1967087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of determination of anti-HCV antibodies].
    Takase K; Tameda Y; Kosaka Y
    Rinsho Byori; 1994 Oct; 42(10):1003-9. PubMed ID: 7527869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.